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Summary
Antisense oligonucleotides complementary to the 5' end of the mRNA encoding the Ly-6A
protein were used to block the expression of that protein. Using this approach we could inhibit
the expression of Ly-6A by 60-80% in antigen-primed lymph node (LN) T cells as well as in
the D10 T cell clone. Inhibition of Ly-6 expression resulted in the inability to restimulate in
vitro, antigen-primed T cells. It also blocked the activation of normal spleen cells by Con A,
monoclonal antibody (mAb) to CD3, and mAb to Ly-6. In contrast, stimulation of normal
spleen cells with the pharmacological agents PMA + ionomycin were unaffected by the inhibition
of Ly-6 expression. Similar results were obtained with the D10 T cell clone; stimulation with
Con A + interleukin 1 (IL-1), antigen-presenting cells (APC), or the clonotypic antibody +
IL-1 was greatly reduced in the presence of antisense oligonucleotides to Ly-6. Stimulation with
PMA + ionomycin was again unaffected. We also studied the effect ofantisense oligonucleotides
on stimulation of preactivated D10 cells. Preactivation of D10 cells with Con A + Ilrl renders
them receptive to secondary stimulation by other lymphokines. In this case, antisense oligo-
nucleotides to Ly-6 had no effect on secondary activation with ID2, IIr4 + IITl, or PMA +
ionomycin. We conclude from these studies that Ly-6 expression is required for T cell receptor
(TCR)-mediated T cell activation.
T
he murine Ly-6 alloantigens are encoded by members
of a multigene family located on chromosome 15
(1-3). The Ly-6 alloantigens are small phosphatidylinositol
(PI)t-anchored, membrane glycoproteins with a molecular
weight of 15,000-18,000 (4-6). Members of the Ly-6 family
are expressed on the surface of a large number of different
cell types, including T cells, B cells, thymocytes, macrophages,
neutrophils, and BM cells (7, 8). Recent studies have shown
that the expression ofthe Ly-6Aencoded protein is associated
with CD4+ T cell activation and the acquisition of immu-
nocompetence during T cell maturationin the thymus (9-13).
It has been postulated that Ly-6 antigens, specifically Ly-6A,
are involved in the transduction of signals originating in the
CD3TCR in CD4+ cells. We addressed this question by
specifically inhibiting Ly-6A antigen expression using antisense
oligonucleotides, and here we show that inhibition ofLy-6A
antigen expression resulted in a dramatic inhibition ofantigen-
and mitogen-driven T cell activation without affecting lym-
phokine or pharmacologically induced T cell response. Thus,
I Abbreviations used in this paper: FGG, fowl gamma globulin; Pl, phos-
phatidylinositol; PPD, purified protein derivative of tuberculin.
it appears as though the Ly-6A antigen plays an important
role in physiological T cell activation through the CD3/TCR
complex.
Materials and Methods
Oligonucleodde. Antisense (5'-AGTTGTGAGAAGTGTCCAT3')
and two control oligonucleotides (5'-GGTCAACGGTGA000-
CAT3; 5'-TCACACTCTTCACAGGTA-3') were synthesized using
a DNA synthesizer (model 380A; AppliedBiosystems, Foster City,
CA). Oligonucleotides were purified on OPC columns (Applied
Biosystems) according to the standard procedure recommended by
the company, or by polyacrylamide gel electrophoresis followed by
elution and passage over a Sephadex G-50 column (Pharmacia Fine
Chemicals, Piscataway, NJ). After purification, oligonucleotides
were resuspended in PBS before use.
Mice
￿
BALB/c and C3H/Hej female mice werepurchased from
the Jackson Laboratories, Bar Harbor, Maine.
T Cell Proliferation Assay.
￿
Mice were primed with 100 jug of
fowl gamma globulin (FGG; Chapel Laboratories, Malvern, PA)
in CFA (Difco Laboratories, Detroit, MI) in the hind footpad. 8 d
later, draining popliteal lymph nodes were removed and 3 x 101
lymph node cells were cultured in 100 Al of RPMI-1640 media
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biotics, L-glutamine, 1% fresh mouse serum, and 5 x 10-5 M
2-ME in a 96-well flat-bottomed tissue culture plate (Falcon Lab-
ware, Lincoln Park, NJ). At time 0, antisense oligonucleotides at
a concentration of 7.0 AM in PBSor PBS alonewere added to cell
cultures . 5or 50 Rg ofFGGor 50 pg ofpurified protein derivative
of tuberculin (PPD ; Staten Serum Institute, Copenhagen, Den-
mark) were added to cultures 0, 24, or 48 h after addition of oligo-
nucleotides . Cultures were incubated for 72 h after the addition
of antigen. Cell proliferation was assayed by the addition of 1.0
ACi ['H]thymidine (6.7 Ci/mmol; New England Nuclear, Boston,
MA) during the last 12-16 h ofculture. Cells were then harvested
andprocessed forliquid scintillationmeasurement ofradioactivity.
Stimulation of the D10.G4 .1 T Cell Clone.
￿
D10.G4.1 T cells (a
conalbumin plus I-At-specific T cell clone) were added to culture
at a concentration of 2 x 10' cells/well in 100 Al ofRPMI-FCS
media . Antisense oligonucleotides at a concentration of 7.0 AM
in PBS or PBS alone were then added to these cell cultures . 24 h
later, 1310 cellswere stimulated with either 10 ng of the anticlono-
typic mAb 3133 + 10-' M rIL1, 50 hg/ml conalbumin + 105
mitomycin C-treatedAKRspleen cells (which serve as APC), 1.5
Ftg/ml ConA + 10-'MrILl, or amixture of 1.0 Ag/ml ofPMA
and 10.0 hg/ml of ionomycin . Cultures were incubated for 72 h
after the addition ofantigen, antibody, or pharmacological agents .
Cell proliferation was assayed as described above.
Lymphokine-induced Proliferation of Preactivated D10.G4 .1 Cells.
D10.G4.1 T cells were activated with 1.5 gg Con A + 10- ' M
IL1 for72hto make these cells receptive to IL2- andIL4-mediated
proliferation (14) . Activated 1310 cells were then harvested, washed,
and added to culture at a concentration of 2 x 10' cells/well in
100P1 ofRPMI-FCS. media . Antisense oligonucleotides at a con-
centration of 7.0AM in PBSor PBSalonewere then added to these
cell cultures. 24 h later, D10 cells were stimulated with either 10
ng ofmAb 3133 + 10'M rIL1, 100U of rIL2, 500U of rIL4
(Amgen Corp., Thousand Oaks, CA) + 10 - 'M rIL1, or a mix-
ture of 1.0 Ag/ml ofPMA and10.0 Ag/mlofionomycin . Cultures
were incubated for 72 h after the addition of antigen, antibody,
or pharmacological agents . Cell proliferation was assayed as de-
scribed earlier.
In Vitro Stimulation ofNaiveSpleen Cells .
￿
Spleencellsfrom naive
BALB/c mice were added to culture at a concentration of 2 x 105
cells/well in 100Al ofRPMI media containing10% FCS . Antisense
oligonucleotides at aconcentration of 10.0 AM were added at time
0 . 24 h later, cells were stimulated with either 1.5 Ag/ml of Con
A; 145.2C11, an anti-CD3 mAb (19) ; 70.94, an anti-Ly-6AmAb
(1) ; or with a mixture of 1 Ag/ml ofPMA and 10 Ag/ml of ion-
omycin . Cultures were incubated for 72 h after the addition of an-
tigen, antibody, or pharmacological agents . Cell proliferation was
assayed as described earlier.
Flow Cytometry.
￿
106 viable cells were resuspended in 100 Al
PBS + 0.1% sodium azide, and stained with biotin-labeled 70.94
(anti-Ly6A), biotin-labeled Jlj (mAb antiThy-1), FITC-RIA72 (rat
mAbanti-mouse CD4), RM2-2 (ratmAbanti-mouse CD2), and
2C11 (hamstermAbanti-mouse CD3) . FITC-streptavidin (Zymed
Laboratories, South San Francisco, CA), FITC-F(ab')2 mouse anti-
rat Ig Qackson ImmunoResearch, West Grove, PA), or FITC-IgG
fraction of goat anti-hamster Ig (Cappel Laboratories) were used
as the second stage reagents. Fluorescence analysis was carried out
on an EPICS Profile Analyzer (Coulter Immunology, Hialeah, FL) .
Results and Discussion
It was recently shown that the presence in vitro ofDNA
oligonucleotides complementary to a portionofmRNA en-
coding a particular protein (antisense oligonucleotides) can
effectively inhibit the translation of that protein in cultured
cells (for review see reference 15).We first studied the effect
of antisense oligonucleotides directed against the Ly-6A
mRNA on secondary in vitro stimulation ofin vivo primed
LN cells. As depicted in Fig. 1 A, LN cells primed to FGG
in CFA responded poorly to FGG and to PPD when re-
stimulated in vitro in the presence of Ly-6A antisense oligo-
nucleotides. Control cultures without oligonucleotides or with
Figure 1.
￿
Inhibition ofT cell proliferation by antisense oligonucleotides to the Ly-6A antigen . (A) FGG/CFA primed LN cells were re-
stimulated in vitro with 5 or 50 jig/ml FGG or 50 ptg/ml PPD 0, 24, or 48 h after the addition of oligonucleotides. Cell proliferation was
assayed 72 h after the addition of antigen (Materials and Methods) . All assays were performed in triplicate. Standard deviations were omit-
ted for simplicity and were generally within 10-15% of the mean . (') Not done . (B) Naive spleen cells were stimulated in vitro with
PMA + ionomycin (PMA + Ca), mAb to Ly-6A (Ly-6A), mAb to CD3 (CD3), or Con A 24 h after the addition of oligonucleotides .
Cell proliferation was assayed 72 h later. Results are presented as the mean response of triplicate cultures t SEM .
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ticular experiment, inhibition of proliferation was least ap-
parent at time 0 and most apparent 48 h after the addition
of antisense oligonucleotides. This was not always the case;
in some experiments, the peak of inhibition was seen 24 h
after the addition of the antisense oligonucleotides .
In Fig. 1 B, normal spleen cells were stimulated with the
T cell mitogen Con A, anti-CD3 mAb, anti-Ly-6A mAb,
or the combination ofPMA and ionomycin, a calcium iono-
phore. In the presence of Ly-6A antisense oligonucleotides
T cell activationwas always inhibited exceptwhen the phar-
macological agents PMA and ionomycin were used to in-
duce cellular proliferation (Fig. 1 B) . It is important to note
that all the activation signals that were inhibited by Ly-6A
antisense oligonucleotides have been previously shown to be
delivered through the CD3/TCR complex (11, 14, 16) .
We then tested whether Ly-6A antisense oligonucleotides
could inhibit the proliferation of a cloned CD4+, antigen-
specific T cell line . We used the T cell cloneD10.G4.1(D10),
a conalbumin plus I-Ak-specific Th2 T cell clone (17) . D10
cells were stimulated with either antigen plus I-Ak+ APCs,
Con A + IIA, 3D3 (an anticlonotypic mAb, 18) + ILl,
or PMA + ionomycin . The results illustrated in Fig. 2 show
once again that activation with antiTCR antibodies, mitogen,
and antigen was inhibited in the presence of Ly-6A antisense
oligonucleotides but not in the presence of an irrelevant oli-
gonucleotide (Fig. 2) . Again, activation by PMA + ionomycin
in the presence of Ly-6A antisense oligonucleotides was
unaffected .
The activation pathway of the D10 clone allowed us to
further define the stage of activation where the Ly-6A an-
Figure 2.
￿
Inhibition of proliferation of the antigen-specific T cell
clone D10.G4.1 by antisense oligonucleotides to the Ly-6A antigen.
2 x 104 D10 cells were cultured for 24 h with antisense or control
oligonucleotides and then stimulated with PMA + ionomycin (PMA
+ Ca), Con A + IM, conalbumin + APCs (Ag + MHC), or the
mAb 3D3 + IIrl. Cell proliferation was assayed 72 h later. Results
are presented as the mean response of triplicate cultures t SEM.
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tigen is required . It was previouslyshown that the D10 clone
first requires an activation signal such as Con A + IIrl in
order to be receptive to stimulation by other lymphokines
such as IL2 or 11,4 + IM (14) . In the experiments shown
in Fig. 3, D10 cells were first activated with Con A + IM
for 3 d, washed, and restimulated with IL2, IL-4 + IL1,
3D3 + IL1, or PMA + ionomycin . In this case, the pres-
ence of Ly-6A antisense oligonucleotides had no effect on
the secondary activation by IL2, 114 + IM, or PMA +
ionomycin . Only the physiological activation by the clono-
typic antibody 3D3 + ILl was greatly reduced, since a preac-
tivation step is not required . It seems therefore that once D10
cells receive the first activation signal by Con A + IL1, Ly-
6A is no longer required for activation by other lymphokines .
The inhibitory effects ofLy-6A antisense oligonucleotides
on T cell activation appear to be due to the inhibition of
Ly-6A expression during activation . Flow cytometric anal-
ysis ofLN cells stimulated with FGG in the presence of Ly-
6A antisense oligonucleotides showed that the expression of
Ly-6A membrane antigens was specifically reduced by60-80%
as compared with cells stimulated in the absence ofoligonu-
cleotides or in the presence of irrelevant oligonucleotides (Fig.
4) . The expression of Thy-1 (another PI-linked protein), CD2,
CD3, and CD4, all of which were shown to be involved in
T cell activation, was unaffected (Fig. 4) . Similar selective
reduction of Ly-6A antigen expression by Ly-6A antisense
oligonucleotides was also seen on D10 cells stimulated by
Con A + IM (data not shown) .
These results indicate that the expression of the Ly-6A pro-
tein on the cell surface is required for TCR-mediated activa-
tion ofCD4+ T cells . Thus, activation by antigen + MHC,
mitogen, and antiTCR antibodies was inhibited by Ly-6A-
Figure 3.
￿
Antisense oligonucleotides to Ly-6A do not inhibit
lymphokine-induced proliferation of preactivated D10.G4.1 cells . D10
cells were first activated with Con A + IIA for 72 h . 2 x 104 acti-
vated D10 cells were then cultured for 24 h with antisense or control
oligonucleotides followed by stimulation with PMA + ionomycin
(PMA + Ca), the mAb 3D3 + IIA (3D3 + IM), IL4 + IIA, or
IL2 . Cell proliferation was assayed 72 h later. Results are presented as
the mean response of triplicate cultures t SEM .U Z W
W U
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Figure 4.
￿
Inhibition of membrane Ly-6A antigen expression on cells treated with antisense oligonucleotides to Ly-6A. Primed LN T cells
011d + complement-treated LN cells) were cultured for 24 h with antisense or control oligonucleotides and then stimulated with 50
,tg/ml of antigen. 24 h later cells were harvested and stained with anti-Ly-6A, anti-CD2, anti-CD3, anti-CD4, or anti Thy-1. (Broken lines)
cells from cultures containing Ly-6A antisense oligonucleotides. (Solid lines) cells from cultures containing control oligonucleotides.
specific antisense oligonucleotides, while lymphokine and
pharmacological activation were unaffected. The fact that an-
tisense oligonucleotides can inhibit APC-dependent activa-
tion (mitogen, antigen + MHC, and anti-Ly6A mAb [9,
19]) and APC-independent responses (anti-CD3 and anticlono-
typic mAb + ILA) precludes the possibility that the antisense
oligonucleotides inhibit T cell activation by inhibiting the
expression ofLy-6 antigens only on APC (20). Furthermore,
flow cytometric analysis confirmed the fact that Ly-6A an-
tisense oligonucleotides specifically inhibited Ly-6A expres-
sion on T cells and T cell clones and did not effect expression
of CD2, CD3, and CD4, all of which are surface proteins
important in T cell activation. It was previously shown that
T cell hybridomas lacking the expression of Ly-6A, or cells
treated with phosphatidylinositol phospholipase C (PI-PLC)
to remove all PI-linked proteins (including all Ly-6 proteins),
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duced via theTCR (13). It was also shownthat crosslinking
of the Ly-6 surface proteins by mAbs resulted in T cell acti-
vation, which in the case of Ly-6A antigens, was dependent
upon the presence of the CD3/TCR complex (11) since T
cells that didnotexpress theCD3TCR complex were refrac-
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